Our mothers told us that if we used the masterbatch process, we’d go blind. And what better way to gather some updates to recent posts than to include one that involves said masterbatch process?
First, a retraction John Spevacek noticed when he tried clicking on the link in a Journal of Applied Polymer Science retraction we’d covered: Continue reading A masterbatch: More polymer retractions, gerontology journal lifts paywall, Microbiology notices appear
Human-centric Computing and Information Sciences is retracting a 2012 paper on a “model approach” to e-learning that well, was anything but a model approach to scientific publishing.
The article, “Implications of E-learning systems and self-efficiency on students outcomes: a model approach,” was written by Tanzila Saba, who has been affiliated with institutions in Malaysia and Pakistan.
According to the retraction notice: Continue reading See one, do one, copy one? E-learning paper retracted for plagiarism
What are the chances of successfully duplicating publication in the Journal of Theoretical Probability? Not too high, it seems.
A pair of South Korean authors have gotten a five-year ban from the journal for double-publishing a paper in the math literature.
The article, “Convergence of Weighted Sums for Arrays of Negatively Dependent Random Variables and Its Applications,” was written by Jong-Il Baek and Sung-Tae Park of Wonkwang University in IkSan.
According to the retraction notice: Continue reading Double submission leads to retraction of probability paper — and a publishing ban
A technical hiccup led the Journal of Translational Medicine to double publish a 2012 paper by a pair of researchers from China and the United States, leading to a retraction.
The article is/was titled “Opportunities and challenges of disease biomarkers: a new section in the journal of translational medicine,” and it was written by Xiangdong Wang and Peter Ward — both members of the journal’s editorial board. It appeared in the Nov. 7, 2012 issue of the JTM. And it appeared less than a month later, on Dec. 5.
Continue reading Lost from translation(al) medicine: Publisher error leads to retraction
A cancer researcher whose work was the subject of a lawsuit has retracted his fifth paper, this one from 2004.
Robert Getzenberg, formerly of the University of Pittsburgh and Johns Hopkins, has had two papers on prostate cancer biomarkers retracted, and two on colon cancer. The newly retracted paper is about a potential bladder cancer biomarker.
Here’s the notice from Clinical Cancer Research: Continue reading A fifth retraction for former Pitt and Hopkins oncology researcher Getzenberg
The International Journal of Human-Computer Interaction has retracted four papers about virtual reality for reasons that aren’t quite clear.
The common author of the studies is Dong-Hee Shin of Seoul’s Sungkyunkwan University. Here’s the retraction notice, which is signed by journal editors-in-chief Gavriel Salvendy and Julie Jacko: Continue reading Four papers about gaming and virtual worlds become more virtual and less reality as they’re retracted
The journal Food and Bioproducts Processing has retracted a 2012 article on apple pomace — the remnants of a pressed fruit — by a group from India.
The reason? Turns out the paper “Utility of apple pomace as a substrate for various products: A review,” fell a little to close to the tree.
Here’s the retraction notice: Continue reading Forbidden fruit: apple pomace paper retracted for plagiarism
In what could be a significant blow to a major pharmaceutical company, Nature Medicine is reportedly set to retract a 2010 article by a group of researchers affiliated with a Chinese arm of the drug giant GlaxoSmithKline.
We’re not the first to report the news — you can read coverage of it on In the Pipeline and Pharmalot, for starters — which includes the revelation that Glaxo has fired Jingwu Zang, a co-author of the suspect paper and former senior vice president and head of research and development at the Shanghai facility: in other words, a big fish. (Big enough to have a profile in, well, Nature Reviews Drug Discovery.)
Pharmalot has quoted a Glaxo spokeswoman: Continue reading Glaxo asks Nature Medicine to retract paper by fired company scientist
Do you have a spare $37 that’s just burning a hole in your pocket?
If so, today is your lucky day. You can plunk down your hard-earned cash for a chance to read a retraction notice in Clinical Gerontologist that resulted from a goof by its publisher, Taylor & Francis.
Here’s the notice for “Does Social Desirability Confound the Assessment of Self-Reported Measures of Well-Being and Metacognitive Efficiency in Young and Older Adults?” Continue reading Would you pay $37 to find out that a publisher had mistakenly printed an article twice?
Identity, which bills itself as “An International Journal of Theory and Research,” has retracted a 2013 article by an Italian researcher who stole the work from another author, then published it twice.
The paper, “Behind the mask: A typology of men cruising for same-sex act,” was ostensibly written by Stefano Ramello, an “independent researcher explores the interactions between space, erotic practices, identity, gender and sexuality.” But as the retraction notice explains, Ramello appears simply to have thrown his own name on top of an earlier paper.
Continue reading Identity theft: Psych journal retracts paper on gay sex for plagiarism